JP2010504351A5 - - Google Patents

Download PDF

Info

Publication number
JP2010504351A5
JP2010504351A5 JP2009529369A JP2009529369A JP2010504351A5 JP 2010504351 A5 JP2010504351 A5 JP 2010504351A5 JP 2009529369 A JP2009529369 A JP 2009529369A JP 2009529369 A JP2009529369 A JP 2009529369A JP 2010504351 A5 JP2010504351 A5 JP 2010504351A5
Authority
JP
Japan
Prior art keywords
phenyl
benzazepine
carbonyl
spiro
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009529369A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010504351A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/078917 external-priority patent/WO2008036755A1/en
Publication of JP2010504351A publication Critical patent/JP2010504351A/ja
Publication of JP2010504351A5 publication Critical patent/JP2010504351A5/ja
Pending legal-status Critical Current

Links

JP2009529369A 2006-09-22 2007-09-19 バソプレッシン拮抗薬として使用されるスピロベンズアゼピン類 Pending JP2010504351A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82665406P 2006-09-22 2006-09-22
PCT/US2007/078917 WO2008036755A1 (en) 2006-09-22 2007-09-19 Spiro benzazepines used as vasopressin antagonists

Publications (2)

Publication Number Publication Date
JP2010504351A JP2010504351A (ja) 2010-02-12
JP2010504351A5 true JP2010504351A5 (enExample) 2010-12-02

Family

ID=39030853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009529369A Pending JP2010504351A (ja) 2006-09-22 2007-09-19 バソプレッシン拮抗薬として使用されるスピロベンズアゼピン類

Country Status (14)

Country Link
US (1) US7825110B2 (enExample)
EP (1) EP2078022B1 (enExample)
JP (1) JP2010504351A (enExample)
CN (1) CN101541806A (enExample)
AT (1) ATE532786T1 (enExample)
AU (1) AU2007299818B2 (enExample)
CA (1) CA2665849A1 (enExample)
CY (1) CY1112270T1 (enExample)
DK (1) DK2078022T3 (enExample)
ES (1) ES2374582T3 (enExample)
PL (1) PL2078022T3 (enExample)
PT (1) PT2078022E (enExample)
SI (1) SI2078022T1 (enExample)
WO (1) WO2008036755A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013057944A1 (ja) * 2011-10-19 2013-04-25 興和株式会社 新規なスピロインドリン化合物、及びそれを含有する医薬
RS57732B1 (sr) 2014-07-15 2018-12-31 Gruenenthal Gmbh Supstituisani derivati azaspiro(4.5)dekana
TW201607923A (zh) 2014-07-15 2016-03-01 歌林達有限公司 被取代之氮螺環(4.5)癸烷衍生物
BR112017026173A2 (pt) 2015-07-07 2018-08-14 Japan Tobacco, Inc. Método para produção de derivado de 7h-pirrolo [2,3-d]pirimidina e intermediário do mesmo
US11673900B2 (en) 2016-12-21 2023-06-13 Japan Tobacco Inc. Process for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives and synthetic intermediates thereof
KR102790657B1 (ko) 2017-09-15 2025-04-02 아제반 파마슈티칼스, 인코퍼레이티드 뇌 손상을 치료하기 위한 조성물 및 방법
US20200337590A1 (en) 2018-01-16 2020-10-29 Bayer Aktiengesellschaft Assistance in the treatment of cardiac insufficiency
JP2023537274A (ja) * 2020-08-07 2023-08-31 カスマ セラピューティクス, インコーポレイテッド Trpmlモジュレーター
US20240101568A1 (en) * 2020-11-26 2024-03-28 Shanghai Jemincare Pharmaceutical Co., Ltd Novel benzazepine spiro derivative
CN112939864B (zh) * 2021-01-29 2022-05-06 中国医科大学 螺[苯并[c]氮杂-1,1’-环己基]-3-酮类化合物
EP4491699A1 (de) 2023-07-13 2025-01-15 Klueber Lubrication München GmbH & Co. KG Phthalimidverbindungen als basisöl für schmierstoffzusammensetzungen
WO2026002248A1 (zh) * 2024-06-28 2026-01-02 上海济煜医药科技股份有限公司 作为v2受体拮抗剂的苯并氮杂卓并环衍生物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617302A (en) * 1984-10-15 1986-10-14 Eli Lilly And Company Inotropic agents
JP2905909B2 (ja) * 1991-04-19 1999-06-14 大塚製薬株式会社 バソプレシン拮抗剤
WO1991005549A1 (en) * 1989-10-20 1991-05-02 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5985869A (en) * 1989-10-20 1999-11-16 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
US5849780A (en) * 1992-01-30 1998-12-15 Sanofi 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
FR2686878B1 (fr) * 1992-01-30 1995-06-30 Sanofi Elf Derives du n-sulfonyl oxo-2 indole, leur preparation, les compositions pharmaceutiques en contenant.
US5686624A (en) * 1992-01-30 1997-11-11 Sanofi 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
US5663431A (en) * 1992-01-30 1997-09-02 Sanofi 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
FR2708605A1 (fr) * 1993-07-30 1995-02-10 Sanofi Sa Dérivés du N-sulfonylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
AU5292393A (en) 1992-10-07 1994-04-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5512563A (en) 1993-07-29 1996-04-30 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
US5464788A (en) 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5753648A (en) 1995-01-17 1998-05-19 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
AUPP150098A0 (en) 1998-01-27 1998-02-19 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives
HUP0301590A3 (en) 2000-07-05 2005-01-28 Ortho Mcneil Pharm Inc Nonpeptide substituted spirobenzoazepines as vasopressin antagonists, pharmaceutical compositions containing them and their preparation
AU2002231098A1 (en) * 2000-12-15 2002-06-24 Emory University Nonpeptide agonists and antagonists of vasopressin receptors
US7011898B2 (en) * 2003-03-21 2006-03-14 Air Products And Chemicals, Inc. Method of joining ITM materials using a partially or fully-transient liquid phase
HRP20051005A2 (en) * 2003-06-17 2006-09-30 Janssen Pharmaceutica N.V. Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
RS20050930A (sr) * 2003-06-17 2008-04-04 Janssen Pharmaceutica N.V., Supstituisani spirobenzazepini
CA2637838A1 (en) * 2006-01-20 2007-07-26 Janssen Pharmaceutica N.V. Novel solid forms of (4r)-1-¬4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl|-1,2,3,5-tetrahydro-spiro¬4h-1-benzazepine-4,1'-¬2|cyclopentene|-3'-carboxylic acid

Similar Documents

Publication Publication Date Title
JP2010504351A5 (enExample)
JP2010504352A5 (enExample)
JP4671123B2 (ja) 新規三環性複素環化合物
JP6511430B2 (ja) がんの治療のための化合物および組成物
DK2303895T3 (en) Thiazolyl AND OXAZOLYLISOQUINOLINONER AND methods of use thereof
KR101463653B1 (ko) 디아민 유도체의 제조 방법
JP2010509356A5 (enExample)
JP2010536761A5 (enExample)
JP2008513496A5 (enExample)
JP2015510942A5 (enExample)
WO2001060803A1 (en) Fused imidazolium derivatives
AU2016298962B2 (en) Compounds and pharmaceutical composition associated with ubiquitination-proteasome system
JP6386527B2 (ja) カリウムイオンチャネル阻害剤としてのピロロピリダジン
EP2970179A1 (en) Phthalazines as potassium ion channel inhibitors
JP2016516691A (ja) カリウムイオンチャネル阻害剤としてのイソキノリン
JP2008525513A5 (enExample)
WO2016025359A1 (en) Processes for the preparation of a bace inhibitor
JP2009519988A5 (enExample)
JP2007536262A5 (enExample)
BRPI0719570A2 (pt) Quinazolinas substituídas
JP2007521272A5 (enExample)
US20160009719A1 (en) Pyrrolotriazines as potassium ion channel inhibitors
WO2016027757A1 (ja) 新規2-アミノベンゾイル誘導体
JP2005531580A5 (enExample)
JP5536771B2 (ja) セロトニン作動性活性を有する化合物、その製造方法およびそれを含む医薬組成物